Navigation Links
Goodwin Biotechnology Inc. and Macrocyclics Announce Collaboration
Date:2/10/2010

PLANTATION, Fla. and DALLAS, Feb. 10 /PRNewswire/ -- Goodwin Biotechnology Inc., a full service Contract Biomanufacturing Company and Macrocyclics, Inc., a manufacturer of customized chelating agents, jointly announced today their collaborative agreement on Chelation and Bioconjugation.  The collaboration will strengthen joint customer projects in Nuclear Medicine involving Chelation, Bioconjugation and GMP manufacturing.

"Clinical development programs in nuclear medicine with biotargeted agents require combining chelation chemistry and bioconjugation chemistry to create a product," said Garry E. Kiefer, Ph.D., Chief Executive Officer at Macrocyclics.   "In Goodwin Bio, we found a perfect collaborator to jointly advance diagnostic and therapeutic medicine."

"We are excited about collaborating with Macrocyclics, a company dedicated to the leading-edge development of new chelation chemistry platforms," said Muctarr Sesay, Ph.D., Vice President of Process Development at Goodwin Bio.  "Our integrated cGMP services combined with Macrocyclics' chelation expertise will enhance clinical development programs in nuclear medicine."

About Goodwin Biotechnology, Inc.

Goodwin Bio, (GBI) located in Plantation, FL., is a full service contract biomanufacturing company and specializes in process development and cGMP production of protein based therapeutics for pre-clinical and early phase clinical trials. The products manufactured by Goodwin Bio are being used in clinical trials and the Company has assisted in the preparation of several IND filings for various clients.  GBI caters small to midsize biotech companies, universities, cancer research institutes and various branches of the U.S. Government.

About Macrocyclics, Inc:

Macrocyclics, (Macrocyclics, Inc.) located in Dallas, TX., a manufacturer of customized chelating agents, is dedicated to leading-edge development of new chelation chemistry platforms critical for advancement of diagnostic and therapeutic medicine. A broad library of catalog products designed to meet the needs of basic and applied research customers as well as custom cGMP products and services to accelerate clinical development programs are provided.  Clients are international and include government agencies, scientific investigators, biotech and pharmaceutical companies.

SOURCE Goodwin Biotechnology Inc.


'/>"/>
SOURCE Goodwin Biotechnology Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
2. New White Paper Details Strategies for Biotechnology Companies to Improve EH&S Compliance
3. Thomson Scientific to Host Pharmaceutical Vision - A Users Conference for Information, Regulatory Affairs, Competitive Intelligence and Biotechnology Professionals
4. Lixte Biotechnology Holdings, Inc. Announces the Initial Trading of Its Common Stock Under the Symbol: LIXT
5. Luminex Corporation to Present at Biotechnology Industry Organization Investor Forum
6. An Uncommon Eye: Photography Exhibit by Biotechnology Executive at BHCC Gallery
7. Onyx Pharmaceuticals to Present at Biotechnology Industry Organization Investor Forum
8. Leading Biotechnology Company Grows with StayinFront CRM
9. Kosan Biosciences to Present at the Biotechnology Industry Organization Investor Forum
10. Wyeth Pharmaceuticals Acquires Haptogen Ltd. to Boost Biotechnology Drug Discovery
11. Bionovo to Present at the Biotechnology Industry Organization (BIO) Investor Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young ... cancer. Members of the Class of 2016 were selected from a pool of ... More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published ... how a patient who developed lymphedema after being treated for breast cancer benefitted from ... the paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... is exhibiting at the Pennsylvania Convention Center and will showcase its product’s latest ... ClinCapture will also be presenting a scientific poster on Disrupting Clinical Trials in ...
Breaking Biology Technology:
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing ...  3D medical LCD display is the latest premium product recently added to the range ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/9/2016)... DUBAI , UAE, May 9, 2016 ... choice when it comes to expanding freedom for high ... Even in today,s globally connected world, there ... online conferencing system could ever duplicate sealing your deal ... are obtaining second passports by taking advantage of citizenship ...
(Date:4/26/2016)... India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a product ... and Onegini today announced a partnership to integrate ... solutions.      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ... to provide their customers enhanced security to access ...
Breaking Biology News(10 mins):